PRL-3 disrupts epithelial architecture by altering the post-mitotic midbody position.

Area of Science:

• Cell Biology
• Cancer Research
• Epithelial Biology

Background:

• Epithelial architecture disruption is crucial in cancer development.
• PRL-3 (PTP4A3) is a phosphatase overexpressed in various epithelial cancers.
• Ectopic lumen formation is a hallmark of cancer progression.

Purpose of the Study:

• To investigate the role of PRL-3 (PTP4A3) in disrupting epithelial architecture.
• To elucidate the mechanism by which PRL-3 promotes ectopic lumen formation.
• To validate the role of PRL-3 in breast cancer cell models.

Main Methods:

• Expression of PRL-3 in polarized epithelial cells (MDCK, Caco2) and analysis of cyst formation.
• Knockdown of endogenous PRL-3 in MCF-7 breast cancer cells cultured in 3D structures.
• Microscopic analysis of cell division, spindle orientation, and midbody localization.

Main Results:

• PRL-3 expression induced cell invasion and formation of multiple ectopic lumens in epithelial cysts.
• Knockdown of PRL-3 reversed multiple-lumen formation to single-lumen structures in breast cancer cells.
• PRL-3 accelerated cytokinesis, leading to midbody mispositioning and ectopic lumen formation without affecting spindle orientation or abscission.

Conclusions:

• PRL-3 (PTP4A3) disrupts epithelial architecture, promoting cancer progression through a novel mechanism.
• PRL-3-induced ectopic lumen formation occurs via accelerated cytokinesis and midbody mispositioning.
• Targeting PRL-3 may offer a therapeutic strategy for epithelial cancers.